Vulvar Carcinoma
specificA carcinoma arising from the vulva. It usually affects elderly women but has been observed in premenopausal women as well. The most frequently seen histologic type is squamous cell carcinoma. The most common site of involvement is the labia majora. In many cases, the development of vulvar cancer is preceded by condyloma or squamous dysplasia.
60
Centers
55
Active Trials
—
Cancer Funding
Top Centers for Vulvar Carcinoma(60)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 73.0 |
| 2 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive High-Volume Research Center | 72.2 |
| 3 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 53.1 |
| 4 | NCI Comprehensive Active Research Program | 53.1 |
| 5 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 53.1 |
| 6 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 53.1 |
| 7 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 53.1 |
| 8 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 53.1 |
| 9 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 53.1 |
| 10 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 53.1 |
| 11 | NCI Comprehensive Active Research Program | 53.1 |
| 12 | NCI Comprehensive Active Research Program | 53.1 |
| 13 | NCI Comprehensive Active Research Program | 53.1 |
| 14 | NCI Comprehensive Active Research Program | 53.1 |
| 15 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 53.1 |
| 16 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 53.1 |
| 17 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 53.1 |
| 18 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 53.1 |
| 19 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 53.1 |
| 20 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 53.1 |
| 21 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 53.1 |
| 22 | NCI Comprehensive Active Research Program | 53.1 |
| 23 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 53.1 |
| 24 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 53.1 |
| 25 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 53.1 |
| 26 | NCI Comprehensive Active Research Program | 53.1 |
| 27 | NCI Clinical Active Research Program | 53.1 |
| 28 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 53.1 |
| 29 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 53.1 |
| 30 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 53.1 |
| 31 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 53.1 |
| 32 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 53.1 |
| 33 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 53.1 |
| 34 | Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program | 53.1 |
| 35 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 53.1 |
| 36 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 53.1 |
| 37 | University of Illinois Cancer CenterChicago, IL Active Research Program | 53.1 |
| 38 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program | 53.1 |
| 39 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 53.1 |
| 40 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 53.1 |
| 41 | Active Research Program | 53.1 |
| 42 | Cancer Center at IllinoisUrbana, IL Active Research Program | 53.1 |
| 43 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 53.1 |
| 44 | Penn State Cancer InstituteHershey, PA Active Research Program | 53.1 |
| 45 | The Jackson Laboratory Cancer CenterBar Harbor, ME NCI Basic_laboratory Active Research Program | 53.1 |
| 46 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 53.1 |
| 47 | The University of Vermont Cancer CenterBurlington, VT Active Research Program | 53.1 |
| 48 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 53.1 |
| 49 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 53.1 |
| 50 | Active Research Program | 53.1 |
| 51 | Murtha Cancer Center at Walter Reed BethesdaBethesda, MD Active Research Program | 53.1 |
| 52 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 53.1 |
| 53 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 31.3 |
| 54 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 31.3 |
| 55 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive | 31.3 |
| 56 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 31.3 |
| 57 | Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive | 31.3 |
| 58 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 31.3 |
| 59 | Georgia Cancer Center, Augusta UniversityAugusta, GA | 31.3 |
| 60 | Northwell Health Cancer InstituteNew York, NY | 31.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →